☕️ Here is something I bet you haven’t thought of this week

Howdy! 👋 

Once again we’re off to the races, at least for today anyway with oil sliding, yields down and chips stocks looking to continue their run. 

I hope you’ve got a piece of the action. 

The world is reorganizing itself around themes and in ways that don’t respect Wall Street’s old categories. 

Here’s my playbook.  

1 – How predictable: Apple just changed the game (again) and the media missed it 

Apple hosted its annual developer conference (WWDC) yesterday and unveiled a slew of game changing stuff. (Read) 

Predictably, the media missed it. 

The big three “business” sites have all glossed over it, and I say that as I sit here stunned because I don’t see a single mention on Fox Business, CNBC nor Reuters. 

Anybody who still thinks that headlines are investable ought to do a serious rethink – but that’s another story for another time.  

Keith’s Rule of the Back Page applies, and smart investors know it. 

• Siri rebuilt from scratch — new dedicated app, conversational memory, multi-step task handling, deep integration across every core app on your phone. The Siri everybody made fun of for a decade is gone. 
• Google Gemini under the hood — the new Siri runs on Google's models, meaning Apple — the self-styled privacy-first company — just handed its AI brain to one of its oldest rivals. 
• EU blocked at launch — Siri AI won't be available in Europe this fall, shut out by the Digital Markets Act. 
• Services story — every AI feature announced ties directly back to subscriptions and iCloud+, already Apple's highest-margin business. 
• Supercycle setup — iOS 27 runs on devices back to the iPhone 11, but the full AI experience requires newer hardware. Apple just gave a billion-plus existing users a reason to upgrade. 

Look, the pundit parade will tell you Apple is late, behind, and out of ideas but – thing is – that’s been their tune for 20 years.  

Apple, meanwhile, has returned ~16,478.36% over that time frame and changed our planet forever… enough to turn every $1,000 invested back then into $165,783.60 today. The S&P 500, by comparison, has returned ~488.72%. 

So, yeah… you can buy the S&P 500 index again and probably do okay. But once again, the lesson is clear. You’ve got to own more of the stocks making “must have” products and services if you really want the opportunity to pull ahead. 

Yesterday it gave 2.5 billion apple device owners reason to upgrade, to buy more services and renew subscriptions. 

Let that sink in. 

My analysis suggests that the Supercycle gap cycle gap will be roughly $106B by FY2028… larger than most S&P 500 companies today. 

People are busy coming up with reasons not to buy Apple, but what you really want to thinking about as an investor is what if they “get it all right.” And the question you want to be asking yourself is can you afford to miss that kind of profit potential.  

I don’t know too many investors who can. 

Keith's Investing Tip: Not every company needs to win the AI race. Some just need to be the place where dang near everyone runs it. Buy the best, ignore the rest®. 

2 – Gee, where have we heard that before 

Citi is out this morning with a new note. 

Gold could “fall another 20% from here.” (Read) 

As much as I hate the expression, I told you so… I have repeatedly. Right here in the 5 with Fitz, on national TV, at conferences and so on. 

And yep, people fought me tooth and nail every step of the way using every argument in the book… macro climate consideration, the Fed, politics, the dollar and so on. 

I can only shake my head. 

Another 20% from here would put it at roughly $3,500 an oz or right about the ~36% decline that I said was coming when gold topped out at roughly $5,400 in January. 

If you are buying gold and think you’re buying the metal, you’ve got another thing coming. 

What you’re really buying is the institutional plumbing stacked on top. 

There may be as much as $50 in phantom money for every real $1 invested in the shiny stuff. 

MyPOV: Tread carefully and think even more carefully if you’re gonna own it (which I encourage in small amounts because it can help stabilize overall portfolio volatility NOT because I think it’s going to rise to a bazillion dollars an ounce. 

Btw, the fabulous Suze Orman and I spoke in detail about gold during a recent webinar which, if you haven’t yet seen it, can be found here. 

Trade Idea: Putskies. 

3 – Has Beijing stolen enough AI chips to make a go of it? 

Beijing is drafting plans for a nationwide network of AI data centers — government agencies writing the blueprint, state telecoms running the show. $295 billion over five years. The most aggressive AI infrastructure bet they've ever made. (Read) 

And almost immediately on the very same morning, Taiwan said it's considering cutting off the chips needed to run it.  

The US has restricted China's access to advanced AI chips since 2022. Now Taiwan — the island that actually manufactures them — is weighing in too.  

The real agenda is more nuanced. 

And that is? 🤷🏻‍ 

To close the smuggling loopholes that have “helped” Nvidia-powered servers find their way to Beijing anyway where they can be reverse engineered and put into production by Chinese companies getting the nod from Beijing. 

Now and before you have a Pavlovian reaction… 

Loads of investors are going to think that this is bad for Nvidia and other chip makers because it potentially negatively impacts sales.  

Fine, but that’s not the real message. 

Every dollar Beijing spends proving they don't need Nvidia is a dollar that proves exactly the opposite. MyPOV is that Nvidia’s products have reached the point where they couldn’t be more relevant. 

I trust you know what to do and which strategies could help you do that very effectively. 

If not, you know where to find me. 

4 – Could fake meat stocks make a comeback? 

A few years back, companies peddling "fake meat" were all the rage as stocks like Beyond Meat (BYND), Oatly (OTLY), and Tattooed Chef (TTCF) cruised higher. Then, predictably, fell back to earth. 

I told you to steer clear — and if you listened, you dodged a catastrophe.  

Beyond Meat has shed roughly 97% from its 2019 peak and is currently fighting a Nasdaq delisting notice after trading below $1 a share for 30 consecutive business days.  

The whole category is still messier than an overused range yard. 

Now, I find myself wondering if they could be ready for a comeback as I watch news out of Texas about the USDA’s response to the flesh-eating New World Screwworm which could devastate the thinnest US cattle herds in 75 years. 

Beef prices could skyrocket which is an investment opportunity all its own but I’m more focused on what I call “synthetic biology” – an investment theme that’s been on my radar for a few years and which has nothing to do with the Beyond Burger crew. 

Hmmm. 

Keith's Investing Tip: Despite what most investors think, my experience is that the best turnaround stories aren't about the companies that got popular — they're about the underlying problems those companies tried to solve. Sometimes the problem outlasts the hype by a decade which means “solving” it the second or third time around is where the real money can be made. 

5 – Here’s something I bet you haven’t thought of this week 

It’s a logical progression. 

The next drug your doctor prescribes might have been made in space. (Read) 

No, really. 

Pharmaceutical companies are sending drug compounds to low Earth orbit — and getting better medicines back. 

Let me explain. 

Gravity constantly disrupts drug manufacturing on Earth. Particles sink, fluids separate, crystals form unevenly. The result is medicines that are harder to deliver, less stable, and more expensive to store. But remove gravity from the equation and suddenly drug crystals grow more uniform, more stable, and easier to administer.  

Think about what this would mean for painful hospital infusions becoming simple at-home injections – something the OBA Family has a handle on already because we talked about it along with a specific new recommendation in this month’s issue, btw. 

For example, Merck used space research on Keytruda — their blockbuster cancer drug — to develop an injectable version patients can administer themselves. FDA approved it in 2025. Eli Lilly and Bristol Myers Squibb are quietly doing the same. 

MyPOV: Most people look at the space economy and think rockets and satellites. Fair enough. But the more I dig into this, the more I think medicine could be where the real near-term impact lands. Morgan Stanley thinks the space economy hits $1 trillion by 2040. 

We've already got two names in the OBA Portfolio® that link nicely to this theme — one directly, one thematically. 

Bottom Line 

Many investors are stuck like a deer in the headlights. Quite a few have no idea what to do or how to do it so they’re doing nothing. 

The words of Japanese monk and my favorite master gardener Shunmyō Masuno come to mind.  

 “When you are uncertain, simplicity is the best way to go.”   

Now and as always, let's MAKE it a great day! 

You got this — I promise! 

Keith 😀